The Montreal Cognitive Assessment as a Screening Tool for Preoperative Mild Cognitive Impairment in Geriatric Patients

The Montreal Cognitive Assessment as a Screening Tool for Preoperative Mild Cognitive

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01496222

Acronym

MoCA

Enrollment

582

Registered

2011-12-21

Start date

2012-01-31

Completion date

2016-04-30

Last updated

2016-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Keywords

mild cognitive impairment, Montreal Cognitive Assessment test

Brief summary

This is a prospective, double-blinded, control trial. The Montreal Cognitive Assessment is used to screen preoperative mild cognitive impairment in 582 consecutive geriatric patients, scheduled for general, vascular or urological surgery under general and/or regional anesthesia.

Detailed description

At the preoperative visit, the co-researcher invites 322 general and vascular patients (male 190, female 132) and 260 urological patients (male 220, female 40) who meet the inclusion criteria to join the study. The process of the project is explained to the interested patients in details before an informed consent is obtained. All participants are interviewed by using the Montreal Cognitive Assessment test. The history of drug used preoperatively (medication reconciliation) has also been recorded.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

65 Years to No maximum

Healthy volunteers

Inclusion criteria

* male or female aged 65 yr, ASA I-III scheduled for elective general, vascular or urological surgery under general and/or regional anesthesia.

Exclusion criteria

* unable to communicate in reading and writing * psychosomatic patients * insulin-dependant diabetes * renal insufficiency (creatinine \>1.5 mg/dL), renal dialysis * uncontrolled congestive heart failure (American Heart Association Classification III or IV congestive heart failure), unstable angina, untreated cardiac arrhythmia * active gastrointestinal bleeding.

Design outcomes

Primary

Measure	Time frame
Incidence of mild cognitive impairment in preoperative geriatric patients	1 Year

Secondary

Measure	Time frame	Description
Relationship between mild cognitive impairment and drug used preoperatively in geriatric patients	1 year	Pearson correlation coefficient will be used to evaluate the relationship between mild cognitive impairment and drug used preoperatively in geriatric patients.

Countries

Thailand

Outcome results